Pasar al contenido principal

Nano-engineered and bio-inspired materials applied in biomedicine

RYC2024-050017-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Recursos Humanos
Subprograma Subprograma Estatal de Formación, Atracción y Retención del Talento Investigador e Innovador
Convocatoria Ramón y Cajal
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microfluidic-assisted coating of nanoparticles by membranes from extracellular vesicles

  • Alonso-Campos, Pablo
  • Balas, Francisco
  • Hueso, José L.
  • Sebastián, Víctor
  • Sancho‐Albero, María
  • Santamaría, Jesús
Extracellular vesicle (EV)-based nanotherapies represent a promising alternative in cancer nanomedicine thanks to their targeting properties. However, two major issues remain when combining nanoparticles (NPs) with EVs: (1) safety concerns of cancer-derived EVs related to their oncogenic nature and (2) lack of robust, reproducible, and efficient strategies for NPs coating with EVs membranes. To overcome these main challenges, in this study, we have combined a microfluidic platform to direct the reassembly of previously isolated EVs-derived membranes from lung cancer cells onto fluorescent silica NPs (FSNs). These FSNs leverage the versatile surface functionalization of silica NPs together with intrinsic fluorescent properties for precise intracellular tracking of our hybrids, avoiding membrane-labeling fluorescent probes. While preserving the tumor-targeting properties of natural lung cancer-derived EVs, the proposed microfluidic strategy offers superior handling and manipulation of the process to guarantee (1) homogeneous EV-like coating (6.3 nm thick), (2) high reproducibility, (3) efficient coating yields (87.8% of the NPs were coated), and (4) selective tumor-targeting properties (8.0- and 4.3-fold increases for parental A549 tumoral cells compared to HeLa and fibroblasts at 4 h, respectively). This technology enables the fabrication of biomimetic hybrid core–shell structures with high precision and stability in a continuous process that is more amenable to scaling up., The authors thank the Spanish Government, University, Innovation and Science Ministry (CONCERT project). PAC thanks the Spanish Government for a FPU PhD research fellowship. VS acknowledges funding from project PID2024160339OB-I00 and PID2021-127847OB-I00 MCIN/AEI/ 10.13039/501100011033. MS-A thanks the AECC for postdoctoral research fellowship funding (POSTD234966SANC), “Ayuda a Talento AECC 2023,” and for a Ramón y Cajal Fellowship (RYC2024-050017-I). The group thanks the Spanish National Research Council (CSIC) (Beca JAE Intro 2024). We thank “Centro de Excelencia Severo Ochoa” (CEX2023-001286 S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Extracellular vesicles as nanoparticle delivery vectors in cancer therapy

  • Sancho‐Albero, María
  • Martín-Pardillos, Ana
  • Hueso, José L.
  • Sebastián, Víctor
  • Santamaría, Jesús
Three decades after the approval of the first cancer nanomedicine, low (<1%) tumor delivery remains the central unsolved challenge in nanoparticle (NP)-based therapy. This barrier has prompted a research shift toward biologically derived delivery systems able to reduce immune clearance while preserving tumor-homing capabilities. In particular, extracellular vesicles (EVs) seem obvious candidates on account of their intrinsic biocompatibility, cell-specific tropism, and biological functionality. In this mini-review, we critically analyze EVs as nanoparticle delivery vectors in cancer therapy. We describe current EV engineering approaches, including loading methodologies, surface modification strategies, and the development of artificial or biomimetic EVs, highlighting technical, scalability, and characterization challenges. We also summarize key in vitro and in vivo results, addressing encapsulation strategy, biodistribution, and therapeutic outcomes. From this discussion, we outline research needs that must be addressed to develop EV–NP hybrids as tools to overcome the delivery challenge in cancer., Authors are thankful for the support from the Spanish Ministry of Science, Innovation and Universities from the Spanish Government (grants PID2023-148732NB-I00 and PID2024-160339OB-I00), the European Research Council (ERC-Advanced Grant ROMEO number 101201543), and Severo Ochoa Excellence Program: CEX2023-001286-S. M.S.-A. acknowledges the Spanish Ministry of Science, Innovation and Universities from the Spanish Government a Ramón y Cajal Fellowship (RYC2024-050017-I)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Microfluidic-Assisted Coating of Nanoparticles by Membranes from Extracellular Vesicles

  • Alonso-Campos, Pablo
  • Balas, Francisco
  • Hueso, Jose L.
  • Sebastián, Víctor
  • Sancho-Albero, María
  • Santamaría, Jesus
Extracellular vesicle (EV)-based nanotherapies represent a promising alternative in cancer nanomedicine thanks to their targeting properties. However, two major issues remain when combining nanoparticles (NPs) with EVs: (1) safety concerns of cancer-derived EVs related to their oncogenic nature and (2) lack of robust, reproducible, and efficient strategies for NPs coating with EVs membranes. To overcome these main challenges, in this study, we have combined a microfluidic platform to direct the reassembly of previously isolated EVs-derived membranes from lung cancer cells onto fluorescent silica NPs (FSNs). These FSNs leverage the versatile surface functionalization of silica NPs together with intrinsic fluorescent properties for precise intracellular tracking of our hybrids, avoiding membrane-labeling fluorescent probes. While preserving the tumor-targeting properties of natural lung cancer-derived EVs, the proposed microfluidic strategy offers superior handling and manipulation of the process to guarantee (1) homogeneous EV-like coating (6.3 nm thick), (2) high reproducibility, (3) efficient coating yields (87.8% of the NPs were coated), and (4) selective tumor-targeting properties (8.0- and 4.3-fold increases for parental A549 tumoral cells compared to HeLa and fibroblasts at 4 h, respectively). This technology enables the fabrication of biomimetic hybrid core−shell structures with high precision and stability in a continuous process that is more amenable to scaling up.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Stimuli‐responsive silsesquioxane nanozymes for organocatalysis in water and prodrug activation in cells

  • Zahid, Rabia
  • Lázaro, Ariadna
  • Moreno-Alcántar, Guillermo
  • Sancho-Albero, María
  • Picchetti, Pierre
Synthetic nanozymes have emerged as promising alternatives to natural enzymes for catalytic and therapeutic applications, yet their limited stability, aqueous compatibility, and catalytic scope impede broader utilization. Here, we report a mild, one‐step sol–gel synthesis that yields ultrasmall, water‐stable octa‐amino silsesquioxanes functioning as metal‐free nanozymes. These minimalistic nanostructures exhibit aldolase‐like organocatalytic activity in water and enable dynamic, stimuli‐responsive modulation of catalysis through reversible supramolecular aggregation and disaggregation triggered by specific chemical inputs, thus forming a multifunctional platform for tunable catalysis and biomedical applications. Structural simplicity, stability, and functional versatility together permit tunable, enzyme‐like catalysis in water without auxiliary surfactants or phase‐transfer additives. Furthermore, the nanozymes display high biocompatibility and efficient cellular internalization, enabling their use in living cells, for instance, as intracellular prodrug activators via retro‐aldol activation of a doxorubicin prodrug in human glioblastoma and metastatic melanoma cells, resulting in selective cytotoxicity. This system provides a cost‐effective, sustainable, and scalable platform for water‐compatible, metal‐free organocatalysis that bridges abiotic catalysis and biological function. These findings demonstrate how rationally designed silsesquioxane frameworks can emulate natural enzyme reactivity while integrating adaptive, stimuli‐responsive behavior, broadening the applicability of synthetic nanozymes to catalytic and therapeutic contexts.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Extracellular Vesicles as Nanoparticle Delivery Vectors in Cancer Therapy

  • Sancho-Albero, Maria
  • Martín-Pardillos, Ana
  • Hueso, Jose L.
  • Sebastián, Víctor
  • Santamaria, Jesús
Three decades after the approval of the first cancer nanomedicine, low (<1%) tumor delivery remains the central unsolved challenge in nanoparticle (NP)-based therapy. This barrier has prompted a research shift toward biologically derived delivery systems able to reduce immune clearance while preserving tumor-homing capabilities. In particular, extracellular vesicles (EVs) seem obvious candidates on account of their intrinsic biocompatibility, cell-specific tropism, and biological functionality. In this mini-review, we critically analyze EVs as nanoparticle delivery vectors in cancer therapy. We describe current EV engineering approaches, including loading methodologies, surface modification strategies, and the development of artificial or biomimetic EVs, highlighting technical, scalability, and characterization challenges. We also summarize key in vitro and in vivo results, addressing encapsulation strategy, biodistribution, and therapeutic outcomes. From this discussion, we outline research needs that must be addressed to develop EV–NP hybrids as tools to overcome the delivery challenge in cancer.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Biomolecular Corona of Extracellular Vesicles: Report on Isev Workshop

  • Paolini, Lucia
  • Tassoni, Selene
  • Al-Jamal, Khuloud T.
  • Banquy, Xavier
  • Beke-Somfai, Tamás
  • Bergese, Paolo
  • Boros, Fanni Annamária
  • Bottini, Massimo
  • Boyd, Ben
  • Busatto, Sara
  • Bussolati, Benedetta
  • Canepa, Ester
  • Castagnola, Valentina
  • Clayton, Aled
  • Dawson, Kenneth
  • El-Andaloussi, Samir
  • Försönits, András
  • Fortunato, Orazio
  • Frigerio, Roberto
  • Gabrielli, Martina
  • Grange, Cristina
  • Guescini, Michele
  • Hayashi, Yuya
  • Hemmingsen, Jonas Klejs
  • Kim, Seungmin
  • Kinga, Ilyes
  • Kyykallio, Heikki
  • Lenassi, Metka
  • Lima, Luize Goncalves
  • Mahoney, M¿ G.
  • Vandenbroucke, Camille Menaceur
  • Möller, Andreas
  • Musicò, Angelo
  • Nelissen, Inge
  • Nogueira, Lucas Fabrício Bahia
  • Nöhammer, Christa
  • Parisse, Pietro
  • Ramassamy, Charles
  • Roballo, Kelly Cristine Santos
  • Salvati, Anna
  • Sancho-Albero, María
  • Shelke, Ganesh
  • Shirmast, Paniz
  • Sonallya, Tasvilla
  • Szigyártó, Imola Csilla
  • van Eijndhoven, Monique A. J.
  • Viitala, Tapani
  • Wang, Shan
  • Yan, Yan
  • Zendrini, Andrea
  • Buzás, Edit
  • Radeghieri, Annalisa
The concept of the “biomolecular corona” (BC) was first introduced to describe the spontaneous absorption of molecules, mainly proteins, onto the surface of synthetic nanoparticles upon exposure to biological fluids. More recently, the same term has been used to describe biomolecules that dynamically interact with the surface of extracellular vesicles (EVs) during their biogenesis, secretion, or upon exposure to intracellular or extracellular milieus, including biological fluids. The EV biomolecular corona is a key determinant of EV identity, shaping their cellular uptake, biodistribution, and functional outcomes in both physiological and pathological contexts. EVs, in contrast to synthetic nanoparticles, introduce distinct challenges and perspectives due to their biological origin, innate heterogeneity, and complex combination of physicochemical and biological properties. To address this evolving topic, the International Society for Extracellular Vesicles (ISEV) organized a dedicated workshop in Brescia, Italy, on 27th to 28th February, 2025. The event gathered selected participants from academia and industry, with expertise spanning synthetic nanomaterials, EVs, biophysics, and translational nanomedicine. The program included keynote lectures, oral presentations, posters, and a series of interactive roundtables structured around fundamentals of the biomolecular corona, EV corona biogenesis and composition, analytical and separation tools and clinical and diagnostic potential applications. This report summarizes the key scientific insights, methodological challenges, conceptual debates, and future perspectives that emerged from the workshop.